跳至主要内容
临床试验/NCT05907655
NCT05907655招募中不适用

Discovering the Functional Role of the Glymphatic System in the Genesis of the Migraine Attack

IRCCS San Raffaele1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2023年4月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
50
试验地点
1
主要终点
Change from baseline glymphatic function after nitroglycerin administration

研究概览

简要总结

This study aimed to investigate the role of the glymphatic system in the initiation of migraine attacks, using non-invasive magnetic resonance imaging techniques and a validated model of migraine induction by nitroglycerin administration. Secondarily, the relationship between the function of the glymphatic system during nitroglycerin-induced migraine attacks and sleep architecture and plasma levels of migraine-involved neuropeptides will be investigated.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • For patients:
  • Diagnosis of migraine, by the ICHD-3 criteria;
  • For both patients and healthy controls:
  • Age between 18 and 60 years;
  • Willing and able to comply with scheduled visits.
  • Exclusion criteria
  • For patients:
  • Overuse of acute medications for headache;
  • Continuous or daily headache;
  • Other primary headache disorders, with the exception of infrequent tension-type headache.
  • For healthy controls:
  • Any subject with frequent tension type headache, migraine, cluster headache, other pain syndromes or neurological conditions.
  • For both patients and healthy controls:
  • Allergy to nitroglycerin;
  • Major psychiatric disorders such as bipolar affective disorder and schizophrenia;
  • Cardiovascular diseases that contraindicated the use of nitroglycerin;
  • Intracranial hypertension;
  • Cerebral haemorrhage;
  • Cerebral trauma;
  • Pulmonary toxic oedema;
  • Closed angle glaucoma;
  • Pregnancy and breastfeeding;
  • Aortic stenosis or significant hypotension (SBP<90mmHg or <100mmHg and symptomatic) precluding nitroglycerin administration;
  • Use of sildenafil;
  • Any person unable to lie still within the environment of the MRI scanner for the required period to perform the study;
  • Any person where MRI scanning is contraindicated (metal implants, pacemaker, claustrophobia, etc.);
  • Use of illicit drugs;
  • MRI head showing any brain pathology, such as space-occupying lesions;
  • Any person unable to understand and follow the instructions of the investigators.

排除标准

  • 未提供

研究组 & 干预措施

Healthy controls

Age between 18 and 60 years. Female and males. Right-handed

干预措施: Nitroglycerin 0.3 MG (Drug)

Adult patients with migraine

Diagnosis of migraine, by the ICHD-3 criteria. Age between 18 and 60 years. Female and males. Right-handed

干预措施: Nitroglycerin 0.3 MG (Drug)

Adult patients with migraine

Diagnosis of migraine, by the ICHD-3 criteria. Age between 18 and 60 years. Female and males. Right-handed

干预措施: MRI (Diagnostic Test)

Adult patients with migraine

Diagnosis of migraine, by the ICHD-3 criteria. Age between 18 and 60 years. Female and males. Right-handed

干预措施: Blood sampling (Diagnostic Test)

Adult patients with migraine

Diagnosis of migraine, by the ICHD-3 criteria. Age between 18 and 60 years. Female and males. Right-handed

干预措施: Sleep profiler (Device)

Healthy controls

Age between 18 and 60 years. Female and males. Right-handed

干预措施: MRI (Diagnostic Test)

Healthy controls

Age between 18 and 60 years. Female and males. Right-handed

干预措施: Blood sampling (Diagnostic Test)

Healthy controls

Age between 18 and 60 years. Female and males. Right-handed

干预措施: Sleep profiler (Device)

结局指标

主要结局

Change from baseline glymphatic function after nitroglycerin administration

时间窗: Up to 8 hours

The DTI-ALPS index will be quantified before and after nitroglycerin administration as an indirect measure of the glymphatic function

次要结局

  • Change from baseline plasma levels of neuropeptides after nitroglycerin administration(Up to 8 hours)
  • Change from baseline sleep architecture after nitroglycerin administration(Up to 8 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Roberta Messina

Principal Investigator

IRCCS San Raffaele

研究点 (1)

Loading locations...

相似试验

Study of the Glymphatic System in Migraine | 临床试验